LGR5 and malignant colon neoplasm: In a colon cancer xenograft model, EREG was expressed in both LGR5 (an intestinal stem cell marker)-positive and drug-resistant LGR5-negative cells [102], thereby indicating the involvement of EREG in cancer stemness.